News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

EU medicines agency to restrict use of Otsuka drug

Started by riky, March 23, 2013, 08:00:18 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

EU medicines agency to restrict use of Otsuka drug

<p><a href="http://news.yahoo.com/eu-medicines-agency-restrict-otsuka-drug-105637064--sector.html"><img src="http://l3.yimg.com/bt/api/res/1.2/PsF.TaHfPB2Fk94mp8kfKw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-03-22T105637Z_1_CBRE92L0UEH00_RTROPTP_2_OTSUKA.JPG" width="130" height="86" alt="Receptionist works at the Otsuka Holdings Co headquarters in Tokyo" align="left" title="Receptionist works at the Otsuka Holdings Co headquarters in Tokyo" border="0" /></a>LONDON (Reuters) - The European Medicines Agency said on Friday it was recommending restricting the use of medicines containing cilostazol, sold by Otsuka under the brand name Pletal, following concerns over side effects. A review of evidence found the drug's modest benefit was only greater than its risk of damaging the heart or causing serious bleeding in a limited number of patients. Cilostazol, also sold as Ekistol, is used for treatment of intermittent claudication, or limping, usually as a result of arterial disease. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login